Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Myokardia Inc (MYOK)

$70.40 1.11 (1.55%)

16:20 EST MYOK Stock Quote Delayed 15 Minutes

Volume:

Previous Close $70.40

Market Cap 2.53B

PE Ratio -49.23

EPS -1.43

Volume (Avg. Vol.) 311,800

Day's Range 70.34 - 71.98

52-Week Range 42.25 - 78.28

Dividend & Yield N/A (N/A)

MYOK Stock Predictions, Articles, and Myokardia Inc News

From the Web

Noteworthy Thursday Option Activity: MYOK, USNA, YELP

From Market News Video Feb 13, 2020

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in MyoKardia Inc (MYOK), where a total of 22,519 contracts have traded so far, representing approximately 2.3 million underlying shares. That amounts to about 669% of MYOK's average daily trading volume over the past month of 336,615 shares..

The MyoKardia (NASDAQ:MYOK) Share Price Is Up 475% And Shareholders Are Delighted

From Simply Wall St Jan 29, 2020

Generally speaking, investors are inspired to be stock pickers by the potential to find the big winners. You won’t get it right every time, but when you do, the returns<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-myok/myokardia/news/the-myokardia-nasdaqmyok-share-price-is-up-475-and-shareholders-are-delighted/">Read More...</a></div>

Analysts’ Top Healthcare Picks: Alkermes (ALKS), MyoKardia (MYOK)

From Analyst Ratings Jan 24, 2020

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS – Research Report) and MyoKardia (MYOK – Research Report) with bullish sentiments. Alkermes (ALKS) In a report released today, Chris Shibutani from Cowen & Co. maintained a Buy rating on Alkermes, with a price target

The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics

From Benzinga Jan 16, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 15) 10X Genomics Inc (NASDAQ...

The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance

From Benzinga Jan 15, 2020

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 14.) Adaptimmune...

Best & Worst Performing Mid Cap Stocks for January 14, 2020

From StockNews.com Jan 14, 2020

DNLI – DNLI leads the way today as the best performing mid cap stock, closing up 29.35%.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy